As clinicians, we can daily apply knowledge learned from a few patients with pure amnesia to patients we see often—those who have memory deficits, such as so-called Mild Cognitive Impairment and neurodegenerative diseases, such as Alzheimer's.
There’s no apparent difference in efficacy or safety between anti-epileptic drugs diazepam and lorazepam in treating pediatric status epilepticus (SE)—a finding that challenges the results of some studies.
Recent studies are showing that patients with autoimmune associated epilepsy may respond favorably to immunosuppression and that many of affected patients lack the full-fledged syndromes that have received so much attention.
Autoimmune disorders including rheumatoid arthritis and lupus more than triple the risk of epilepsy in young patients. Early treatment of a rheumatic condition reduces the epilepsy risk, a large study finds.